Alseres Pharmaceuticals, Inc. filed its 10-K on Apr 01, 2013 for the period ending Dec 31, 2012. In this report its auditor, McGladrey LLP - RSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 USD | -50.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 30 | |
-22.83% | 1.45B | |
-19.01% | 56.28M |
- Stock Market
- Equities
- ALSE Stock
- News Alseres Pharmaceuticals, Inc.
- Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt